The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors

Peptides

Volumn 17, Issue 5, 1996, Pages 825-829

  Gourlet, Philippe ^a   Vilardaga, Jean Pierre ^a   De Neef, Philippe ^a   Waelbroeck, Magali ^a   Vandermeers, Andre ^a   Robberecht, Patrick ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Secretin receptors; VIP analogues; VIP1 receptors

Indexed keywords

AMINO ACID RECEPTOR; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMINO ACID ANALYSIS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CHO CELL; DNA TRANSFECTION; ENZYME ACTIVITY; GENE DELETION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0008228191     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00107-6     Document Type: Article

References (21)

1. 1. Ambrosius, D.; Casaretto, M.; Gerardy-Schahn, R.; Saunders, D.; Brandenburg, D.; Zahn, H. Peptide analogues of the anaphylatoxin C3a: syntheses and properties. Biol. Chem. Hoppe Seyler 370:217-227; 1989.
2. 2. Bodanszky, M.; Bodanszky, A. Conformation of peptides of the secretin-VIP-glucagon family in solution. Peptides 7(Suppl. I):43-48; 1986.
3. 3. Christophe, J. P.; Conlon, T. P.; Gardner, J. D. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the Guinea pig: Binding of radioiodinated peptide. J. Biol. Chem. 251:4629-4634; 1976.
4. 4. Ciccarelli, E.; Svoboda, M.; De Neef, P.; Di Paolo, E.; Bollen, A.; Dubeaux, C.; Vilardaga, J.-P.; Waelbroeck, M.; Robberecht, P. Pharmacological properties of two recombinant splice variants of the PACAP type I receptor transfected and stably expressed in CHO cells. Eur. J. Pharmacol. 288:259-267; 1995.
5. 5. Clore, G. M.; Nilges, M.; Brünger, A.; Gronenborn, A. M. Determination of the backbone conformation of secretin by restrained molecular dynamics on the basis of interproton distance data. Eur. J. Biochem. 171:479-484; 1988.
6. 6. Couvineau, A.; Rouyer-Fessard, C.; Fournier, A.; St-Pierre, S.; Pipkorn, R.; Laburthe, A. Structural requirement for VIP interaction with specific receptors in human and rat intestinal membranes: Effect of nine partial sequences. Biochem. Biophys. Res. Commun. 121:493-498; 1984.
7. 7. Fournier, A.; Saunders, J. K.; Boulanger, Y.; St. Pierre, S. A. Conformation analysis of vasoactive intestinal peptide and related fragments, Ann. NY Acad. Sci. 527:51-67; 1988.
8. 1H-NMR study of the solution conformation of secretin. Resonance assignment and secondary structure. FEBS Lett. 215:88-94; 1987.
9. 9. Holtmann, M. H.; Hadac, E. M.; Miller, L. J. Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. J. Biol. Chem. 270:14394-14398; 1995.
10. 10. Ishihara, T.; Nakamura, S.; Kaziro, Y.; Takahashi, T.; Takahashi, K.; Nagata, S. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J. 10:1635-1641; 1991.
11. 11. Ishihara, T.; Shigemoto, R.; Mori, K.; Takahashi, K.; Nagata, S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819; 1992.
12. 12. König, W.; Bickel, M.; Wissmann, H.; Uhmann, R.; Geiger, R. Secretin analogues. In: Rosselin G.; Fromageot, P.; Bonfils, S., eds. Hormone receptors in digestion and nutrition. Amsterdam: North Holland Biomedical Press; 1979:137-143.
13. 13. Murphy, W. A.; Coy, D. H.; Lance, V. A. Superactive amidated COOH-terminal glucagon analogues with no methionine or tryptophan. Peptides 7(Suppl. 1):69-74; 1986.
14. 14. Musso, G. E.; Patthi, S.; Ryskamp, T. C.; Provow, S.; Kaiser, E. T.; Velicelebi, G. Development of helix-based vasoactive intestinal peptide analogues: Identification of residues required for receptor interaction. Biochemistry 27:8174-8181; 1988.
15. 15. O'Donnell, M.; Garippa, R. J.; O'Neill, N. C.; Bolin, D. R.; Cottrell, J. M. Structure-activity studies of vasoactive intestinal polypeptide. J. Biol. Chem. 266:6389-6392; 1991.
16. 16. Robberecht, P.; Conlon, T. P.; Gardner, J. D. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3′:5′-monophosphate. J. Biol. Chem. 251:4635-4639; 1976.
17. 17. Salomon, Y.; Londos, C.; Rodbell, M. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:541-548; 1974.
18. 18. Staun-Olsen, P.; Ottesen, B.; Gammeltoft, S.; Fahrenkrug, J. VIP binding sites on synaptosomes from rat cerebral cortex: Structure binding relationship. Peptides 7(Suppl. 1):181-186; 1986.
19. 19. Vilardaga, J. P.; Ciccarelli, E.; Dubeaux, C.; De Neef, P.; Bollen, A.; Robberecht, P. Properties and regulation of the coupling to adenylate cyclase of the secretin receptor stably transfected in CHO cells. Mol. Pharmacol. 45:1022-1028; 1994.
20. 20. Vilardaga, J.-P.; De Neef, P.; Di Paolo, E.; Bollen, A.; Waelbroeck, M.; Robberecht, P. Properties of chimeric and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. Biochem. Biophys. Res. Commun. 211:885-891; 1995.
21. 21. Vilardaga, J.-P.; Di Paolo, E.; Bollen, A. Improved PCR method for high-efficiency site-directed mutagenesis using class 2S restriction enzymes. Biotechniques 18:605-606; 1995.